Skip to content

Clinical trials

Osteoporosis, Postmenopausal trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Osteoporosis, Postmenopausal Country / region: China Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20121
20131
20142
20161
20183
20196
20202
20212
20223
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status15
Completed10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fujian Academy of Traditional Chinese Medicine3
Mabwell (Shanghai) Bioscience Co., Ltd.2
Second Affiliated Hospital of Soochow University2
Shanghai Biomabs Pharmaceutical Co., Ltd.2
Shenzhen Salubris Pharmaceuticals Co., Ltd.2
Chugai Pharmaceutical1
Eisai Co., Ltd.1
Eli Lilly and Company1
Fifth Affiliated Hospital, Sun Yat-Sen University1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Osteoporosis, Postmenopausal25
Osteoporosis4
Bone Diseases, Metabolic1
Diabetes Mellitus1
Iron Metabolism Disorders1
Low Back Pain1
Osteoporotic Fractures1

Trials

Showing 51 to 25 of 25. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.